8-K filed Aug 6, 2026 at 07:05 ET
Ligand reported Q2 2026 adjusted EPS of $2.37, a 20.3% beat vs consensus of $1.97, driven by 32% YoY royalty revenue growth to $48.0M. The company raised the low end of its 2026 adjusted EPS guidance to $9.00-$9.50 (from $8.50-$9.50) and closed the XOMA Royalty acquisition on July 14, 2026, adding over 120 assets. The strong beat, guidance raise, and transformative acquisition close are clearly positive, but the $700M convertible debt issuance and share repurchase at ~$262 introduce modest dilution and capital structure complexity.